Adolescent mental health problems are the cause of deep distress to hundreds of thousands of teenagers in the UK. Young Minds estimates that 850,000 children and young people in the UK have a diagnosed mental health problem, and many more may be suffering in silence. Statistics on how likely it is that an adolescent with [read the full story…]
There’s been a lot of chatter here in the woodlands about the role of cognitive behavioural therapy (CBT) in psychosis – what do service users think of it? Can it be used in place of antipsychotics for some people? Outside of the woodlands, CBT for psychosis has also been generating a lot of attention: Does [read the full story…]
The National Confidential Inquiry into Suicide and Homicide by People with Mental Illness was established in its current form at Manchester University in 1996. From 1991, prior to the move to Manchester, research in this area had been managed within the Royal College of Psychiatrists. The NCISH has established an outstanding national and international reputation [read the full story…]
Social Anxiety Disorder used to be called Social Phobia and is generally regarded as the most prevalent form of common anxiety disorder. Estimates of lifetime prevalence vary but according to a US study, 12% of adults in the US will have social anxiety disorder at some point in their lives (Kessler et al, 2005). According [read the full story…]
Alcohol use disorder is frequently comorbid with major depressive disorder, and the disease burden associated with this dual diagnosis is considerably greater than that attributed to each disorder in isolation. This creates a problem for clinicians who are trying to treat depressed problem drinkers, because many services are set up to deal with only one [read the full story…]
Last week the media reported widely on a study of ketamine for depression (McShane et al, 2014). As usual the headlines made bold assertions, the Telegraph running with “Horse tranquilliser Ketamine could cure severe depression” (Knapton, 2014). But what did the paper authored by an Oxford group and published in the Journal of Psychopharmacology really [read the full story…]
Depression and anxiety are both common conditions in patients with dementia and mild cognitive impairment (MCI), with some studies finding around 30% of patients show at least some depressive symptoms (Enache et al, 2011). Similarly, a study on vascular dementia found around 70% of participants had two or more symptoms of anxiety (Ballard et al, 2000). [read the full story…]
Psychotic disorders, such as schizophrenia, are often conceptualised as arising from a complex interplay of genetic and environmental influences (Tandon 2008). The impact of social influences on the risk of psychotic experience is undeniable. Recent reviews of this topic have called for a focus on maternal wellbeing as a means of primary prevention for mental [read the full story…]
Standardised (or ‘plain’) packaging of cigarettes requires all branding to be removed, leaving the brand name to be placed in a standard location and font on a standard colour cigarette pack. Apart from the small brand name, the packs would still feature a prominent health warning as well as counterfeiting marks. The aim of standardised [read the full story…]
In spite of widely available different antidepressants, major depression does not respond adequately in up to one third of patients. Overall, the need for both reliable and well-tolerated treatment has remained unmet for a sizeable proportion of people with depression. In the past couple of years, there has been controversy about the suitability of Agomelatine (Valdoxan) [read the full story…]
